Menzies School of Health Research has led the largest-ever study of people living with a unique strain of chronic hepatitis B (C4 hepatitis B)—which predominately affects First Nations Australians in ...

For some people, their immune system can clear the hepatitis B virus with natural immunity. However, some individuals can build immunity to hepatitis B through vaccination. For some people, the ...

Chronic hepatitis B (CHB) is a long-term infection of the liver caused by the hepatitis B virus (HBV). While acute hepatitis B infection is often resolved by the immune system, CHB occurs when the ...

The presence of hepatitis B surface antibodies in the blood indicates a person is recovering from a hepatitis B virus infection. It means that their immunity to HBV is increasing. By testing a ...

Hepatitis B can spread relatively easily through contact with the blood or body fluids of someone who has the virus, especially in certain high risk situations. Hepatitis B is a liver infection caused ...

Chronic hepatitis B (CHB) affects more than 254 million people globally, with 1.2 million new infections occurring each year. 1 And while it has the potential to cause severe long-term liver problems ...

New national hepatitis elimination profiles reveal policy and implementation gaps in reaching global viral hepatitis elimination targets.

The hepatitis B vaccine protects against liver infection caused by the hepatitis B virus (HBV). This virus is highly contagious and can spread through exposure to blood, semen, and other bodily fluids ...

Hepatitis B is a potentially fatal liver disease. It spreads through contact with bodily fluids, and certain groups including health care workers and IV drug users are at higher risk. Anyone can be ...

A new 10-year regional study reveals that adults living with both HIV and hepatitis B virus across the Asia-Pacific face substantially higher risks of kidney dysfunction than those living with HIV ...